1998
DOI: 10.1128/jvi.72.1.671-676.1998
|View full text |Cite
|
Sign up to set email alerts
|

Efficient Infection Mediated by Viral Receptors Incorporated into Retroviral Particles

Abstract: Many host cell surface proteins, including viral receptors, are incorporated into enveloped viruses. To address the functional significance of these host proteins, murine leukemia viruses containing the cellular receptors for Rous sarcoma virus (Tva) or ecotropic murine leukemia virus (MCAT-1) were produced. These receptor-pseudotyped viruses efficiently infect cells expressing the cognate viral envelope glycoproteins, with titers of up to 105 infectious units per milliliter for the Tva pseudotypes. Receptor a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0

Year Published

1998
1998
2018
2018

Publication Types

Select...
6
4

Relationship

2
8

Authors

Journals

citations
Cited by 34 publications
(11 citation statements)
references
References 40 publications
0
11
0
Order By: Relevance
“…The mechanism of sTva inhibition of ASLV(A) infection appears to be by irreversible inactivation of the ASLV virion. In sharp contrast to CD4, which requires a coreceptor for HIV-1 infectivity, Tva appears to be necessary and sufficient to mediate ASLV(A) entry (3,7,72). Binding of sTva to EnvA induces a conformational change in the SU subunit, exposing previously inaccessible protease sites (28), and leads to the formation of stable, higher-order oligomers of the TM subunit (3a) reminiscent of structures for the putative fusogenic forms of influenza HA2 (11,13), Ebola virus GP2 subunits (67), and the murine leukemia virus (MLV) (26) and HIV-1 TM subunits (12,60,68).…”
Section: Discussionmentioning
confidence: 85%
“…The mechanism of sTva inhibition of ASLV(A) infection appears to be by irreversible inactivation of the ASLV virion. In sharp contrast to CD4, which requires a coreceptor for HIV-1 infectivity, Tva appears to be necessary and sufficient to mediate ASLV(A) entry (3,7,72). Binding of sTva to EnvA induces a conformational change in the SU subunit, exposing previously inaccessible protease sites (28), and leads to the formation of stable, higher-order oligomers of the TM subunit (3a) reminiscent of structures for the putative fusogenic forms of influenza HA2 (11,13), Ebola virus GP2 subunits (67), and the murine leukemia virus (MLV) (26) and HIV-1 TM subunits (12,60,68).…”
Section: Discussionmentioning
confidence: 85%
“…Cells expressing the sTva proteins showed significant resistance to ALV(A) infection, presumably due to the secreted receptor proteins binding the glycoproteins of the invading virion, thus blocking the interactions of the virus and the mem- brane-bound Tva, a form of receptor interference. Tva has been hypothesized to be necessary and sufficient to mediate ALV(A) entry (3,6,50). Several possible mechanisms could account for the sTva inhibition of ALV(A) entry.…”
Section: Discussionmentioning
confidence: 99%
“…Retaining the native structure of multispanning membrane proteins during immunization (and later phage-panning steps) is vital for eliciting functionally relevant mAbs, which usually recognize conformational structures on the extracellular membrane protein face. VLPs are noninfectious lipid-enveloped retroviral particles that can present intact multispanning membrane proteins on their surface with native topology and conformation (19)(20)(21). VLPs can capture high levels of structurally intact GPCRs, ion channels, and transporters when the viral particles bud from the plasma membrane and are potent immunogens due to their particulate structure and multivalent epitope organization (22,23).…”
Section: Use Of Vlps For Immunization and Phage Display To Isolate Mabsmentioning
confidence: 99%